Disease severity was associated with significantly enhanced antigen-presenting cell (APC) activation, Th1/Th17 responses, and pathogenic IgG2a production, as well as elevated circulating levels of inflammatory cytokines, indicating an important role for CL-11 in regulating APC activation and limiting autoimmunity (15). The gene discussed is COLEC11; the disease is Autoimmunity.